PEAK6’s Ibere Pharmaceuticals Warrants IBER.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-25,000
Closed -$5K – 5892
2022
Q1
$5K Hold
25,000
– – ﹤0.01% 4910
2021
Q4
$14K Hold
25,000
– – ﹤0.01% 4860
2021
Q3
$15K Hold
25,000
– – ﹤0.01% 4827
2021
Q2
$19K Buy
+25,000
New +$15.2K ﹤0.01% 4737

Other funds holding IBER.WS

PEAK6's IBER.WS Position: Q2 2022 in Review

PEAK6 sold out of Ibere Pharmaceuticals Warrants (IBER.WS) in Q2 2022, closing a stake of 25,000 shares — an estimated $5K sold.

PEAK6 first reported a position in IBER.WS in Q2 2021 and held it in 4 quarters. The position peaked at $19K in Q2 2021. 36 funds tracked by Wall St. Rank hold IBER.WS as of Q2 2022.

  • PEAK6 reported no remaining Ibere Pharmaceuticals Warrants position as of Q2 2022 after selling out during the quarter.
  • PEAK6 sold 25,000 Ibere Pharmaceuticals Warrants shares in Q2 2022, an estimated $5K.
  • PEAK6 first reported a position in Ibere Pharmaceuticals Warrants in Q2 2021 and held it in 4 quarters.
  • PEAK6's Ibere Pharmaceuticals Warrants position peaked at $19K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Warrants as of Q2 2022.

Based on PEAK6's 13F filing for Q2 2022, filed 12 Aug 2022.